Key facts
- It has raised $180.0M across 1 recorded rounds; the latest was PIPE ($180.0M) in Sep 2025.
- 4 institutional filers report fund marks on Oruka Therapeutics across 60 filings.
Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·Watchlist + deal alerts for Oruka Therapeutics
Create free account
No card required
Funding rounds
1 roundsSep 2025PIPE$180.0M▮
About Oruka Therapeutics
- Industry
- Biotechnology
PA Mark — not yet priced
Oruka Therapeutics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Pro members can request priority coverage with a 48-hour turnaround.
Recorded secondary trades
No prints on record
No secondary trades in Oruka Therapeutics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Pro members can request priority coverage with a 48-hour turnaround.
Institutional fund marks
4 filers · latest Jun 20264 SEC-registered funds reported 60 fair-value marks on Oruka Therapeutics between Apr 2025 and Jun 2026. Filer-level marks and implied $/share are available to Pro members.